Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Vipool Goradia

Orthopaedic Surgery Glen Allen, VA Medical Doctor

NPI 1740274836 CMS profile 305747

100 Concourse Blvd, Suite 150, Glen Allen, VA 23059

Open in the dashboard

General payments

$420,449

60 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Vipool Goradia of Glen Allen, VA is reported in the CMS Open Payments database as having received $420,449 across 60 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,087 4
2024 General $12,211 5
2023 General $27,233 10
2022 General $48,891 7
2021 General $57,917 11
2020 General $96,748 13
2019 General $174,363 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Vipool Goradia
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Vipool Goradia were reported at $3,087. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Vipool Goradia Orthopaedic Surgery median Middle half National median
2019 $174,363 $644 $140–$2,844 $163
2020 $96,748 $312 $75–$1,860 $114
2021 $57,917 $520 $117–$2,495 $132
2022 $48,891 $598 $128–$2,731 $149
2023 $27,233 $461 $128–$2,264 $160
2024 $12,211 $497 $134–$2,475 $164
2025 $3,087 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $408,405 27 payments
  2. Bodycad USA Corp $9,927 4 payments
  3. Encore Medical, LP $1,549 14 payments
  4. Heraeus Medical, LLC. $330 10 payments
  5. Zimmer Biomet Holdings, Inc. $138 1 payment
  6. Fortis Surgical, LLC $59 2 payments
  7. DePuy Synthes Sales Inc. $24 1 payment
  8. Avanos Medical $19 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $408,405 27 payments
  2. Consulting Fee $9,875 3 payments
  3. Food and Beverage $1,419 27 payments
  4. Gift $750 3 payments
Products named General payments · program years 2019–2025
  1. KNEE & HIP IMPLANTS MENISCAL REPAIR MENISCAL CINCH $260,089 8 payments
  2. KNEE & HIP IMPLANTS MENISCAL REPAIR SPEED CINCH $260,089 8 payments
  3. ARTHREX Knee & Hip - Implants - Meniscal Repair - Meniscal Cinch $145,253 16 payments
  4. ARTHREX Knee & Hip - Implants - Meniscal Repair - Meniscal Cinch $145,253 16 payments
  5. ARTHREX Knee & Hip - Implants - Meniscal Repair - Speed Cinch $102,269 9 payments
  6. Arthrex Knee & Hip - Implants - Meniscal Repair - Meniscal Cinch - Other $6,125 6 payments
  7. Reflex $5,375 1 payment
  8. DJO SURGICAL Joint Implants $370 4 payments
  9. PALACOS $330 10 payments
  10. DJO SURGICAL Joint Implants $255 1 payment
  11. Other $699 12 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$13,543

Of which drugs: $879

Medicare patients

69

Average age 73

Services billed

319

44 women, 25 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 74%
Diabetes 25%
Osteoporosis 23%
Ischemic heart disease 19%
Depression 19%
COPD 17%
Atrial fibrillation 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 11 96 $79

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

60 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record